STOCK TITAN

Deferred stock award to Elanco (NYSE: ELAN) executive disclosed

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Modi Rajeev A. reported acquisition or exercise transactions in this Form 4 filing.

Elanco Animal Health Inc reported that executive Rajeev A. Modi received a grant of 61.1059 deferred stock units tied to Elanco common stock. Each unit reflects a value of $24.17 per underlying share in the filing.

Following this award, Modi holds a total of 9,463.0201 deferred stock units directly. According to the plan terms, these units will settle in either cash or Elanco common shares after employment ends or in a specified future year under the Executive Deferral and Stock Match Plan.

Positive

  • None.

Negative

  • None.
Insider Modi Rajeev A.
Role SEE REMARKS
Type Security Shares Price Value
Grant/Award Deferred Stock Units 61.1059 $24.17 $1K
Holdings After Transaction: Deferred Stock Units — 9,463.0201 shares (Direct)
Footnotes (2)
  1. F1. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
  2. F2. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.
Deferred stock units granted 61.1059 units Grant to Rajeev A. Modi on 2026-06-12
Implied value per unit $24.17 per unit Price per underlying share used in the Form 4
Total deferred stock units held 9,463.0201 units Direct holdings after the grant
Deferred Stock Units financial
"Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent."
Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.
Executive Deferral and Stock Match Plan financial
"Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan."
Grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did Elanco (ELAN) disclose for Rajeev A. Modi?

Elanco disclosed that executive Rajeev A. Modi received 61.1059 deferred stock units as a compensation-related grant. These units are tied to Elanco common stock and increase his total deferred stock unit holdings to 9,463.0201, as reported in the Form 4 filing.

How many Elanco (ELAN) deferred stock units does Rajeev A. Modi hold after this grant?

After the reported grant, Rajeev A. Modi holds 9,463.0201 deferred stock units. This total includes the new 61.1059-unit award disclosed in the Form 4, all held directly and linked to Elanco common stock under the company’s compensation and deferral arrangements.

What does each deferred stock unit represent for Elanco (ELAN) executives?

Each deferred stock unit represents the right to receive one share of Elanco common stock or its cash equivalent. Settlement occurs later, rather than immediately, giving executives future value linked to the company’s stock while aligning compensation with longer-term performance outcomes.

When will Rajeev A. Modi’s Elanco (ELAN) deferred stock units be settled?

The deferred stock units will settle in cash or Elanco common shares after employment ends or in a specified future year. Settlement timing follows the terms of Elanco’s Executive Deferral and Stock Match Plan as described in the Form 4 footnotes.

Is the Elanco (ELAN) Form 4 transaction a market purchase or sale of stock?

No, the Form 4 shows a compensation-related grant of deferred stock units, not an open-market purchase or sale. The transaction is coded as an acquisition (A) representing a grant or award, and the units settle later in cash or Elanco shares.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Modi Rajeev A.

(Last)(First)(Middle)
C/O ELANCO ANIMAL HEALTH INCORPORATED
450 ELANCO CIRCLE

(Street)
INDIANAPOLIS INDIANA 46221

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Elanco Animal Health Inc [ ELAN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
SEE REMARKS
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/12/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Deferred Stock Units(1)06/12/2026A61.1059 (2) (2)Common Stock61.1059$24.179,463.0201D
Explanation of Responses:
1. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
2. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.
Remarks:
Executive Vice President U.S. Pet Health and Global Digital Transformation
/s/ Amy C. Seidel, as Attorney-in-Fact for Rajeev A. Modi06/16/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)